Education
About Us
Working with TipRanks
Follow Us
TNF Pharmaceuticals (TNFA)
NASDAQ:TNFA
Total Valuation
TNF Pharmaceuticals has a market cap or net worth of $2.47M. The enterprise value is ―.
Market Cap$2.47M
Enterprise Value―
Share Statistics
TNF Pharmaceuticals has 14,184,088 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,184,088
Owned by Insiders0.27%
Owned by Institutions0.20%
Financial Efficiency
TNF Pharmaceuticals’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -132.50%.
Return on Equity (ROE)-0.31
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-132.50%
Return on Capital Employed (ROCE)-1.33
Revenue Per Employee0.00
Profits Per Employee-2.00M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of TNF Pharmaceuticals is -0.74. TNF Pharmaceuticals’s PEG ratio is <0.01.
PE Ratio-0.74
PS Ratio0.00
PB Ratio0.05
Price to Fair Value0.23
Price to FCF-0.10
Price to Operating Cash Flow-0.09
PEG Ratio<0.01
Income Statement
In the last 12 months, TNF Pharmaceuticals had revenue of 0.00 and earned -4.00M in profits. Earnings per share was -5.33.
Revenue0.00
Gross Profit0.00
Operating Income-17.12M
Pretax Income-4.00M
Net Income-4.00M
EBITDA-4.00M
Earnings Per Share (EPS)-5.33
Cash Flow
In the last 12 months, operating cash flow was -10.14M and capital expenditures 0.00, giving a free cash flow of -10.14M billion.
Operating Cash Flow-10.14M
Free Cash Flow-10.14M
Free Cash Flow per Share-0.72
Dividends & Yields
TNF Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta>-0.01
52-Week Price Change-91.54%
50-Day Moving Average0.26
200-Day Moving Average1.01
Relative Strength Index (RSI)40.23
Average Volume (3m)2.97M
Important Dates
TNF Pharmaceuticals upcoming earnings date is May 20, 2019, TBA Not Confirmed.
Last Earnings DateApr 1, 2019
Next Earnings DateMay 20, 2019
Ex-Dividend Date―
Financial Position
TNF Pharmaceuticals as a current ratio of 1.17, with Debt / Equity ratio of 0.11%
Current Ratio1.17
Quick Ratio1.17
Debt to Market Cap0.00
Net Debt to EBITDA0.66
Interest Coverage Ratio0.00
Taxes
In the past 12 months, TNF Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
TNF Pharmaceuticals EV to EBITDA ratio is -0.08, with an EV/FCF ratio of -0.02.
EV to Sales0.00
EV to EBITDA-0.08
EV to Free Cash Flow-0.02
EV to Operating Cash Flow-0.02
Balance Sheet
TNF Pharmaceuticals has $10.64M in cash and marketable securities with $18.29K in debt, giving a net cash position of -$10.62M billion.
Cash & Marketable Securities$10.64M
Total Debt$18.29K
Net Cash-$10.62M
Net Cash Per Share-$0.75
Tangible Book Value Per Share$1.47
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for TNF Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―